Uterine contraction in the development of Mobius syndrome

Journal of Child Neurology

Volumn 12, Issue 3, 1997, Pages 225-227

  Graf, William D ^a   Shepard, Thomas H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFERGOT;

ARTICLE; BRAIN STEM INJURY; CASE REPORT; CLINICAL FEATURE; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; INFANT; MOEBIUS SYNDROME; PATHOGENESIS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; UTERUS CONTRACTION;

EID: 0030896761     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200315     Document Type: Article

References (29)

1. Kumar D: Moebius syndrome. J Med Genet 1990;27:122-126.
2. Gorlin RJ, Cohen MM Jr, Levin LS (eds): Syndromes of the Head and Neck, 3rd ed. New York, Oxford University Press, 1990.
3. D'Cruz OF, Swisher CN, Jaradeh S, et al: Möbius syndrome: Evidence for a vascular etiology. J Child Neurol 1993;8:260-265.
4. Sudarshan A, Goldie WD: The spectrum of congenital facial diplegia (Moebius syndrome). Pediatr Neurol 1985;1:180-184.
5. Lipson AH, Webster WS, Brown-Woodman PDC, Osborn RA: Moebius syndrome: Animal model-human correlations and evidence for a brainstem vascular etiology. Teratology 1989;40:339-350.
6. Silberstein SD, Young WB: Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995;45:577-584.
7. Narod SA, De-Sanjos'e S, Victora C: Coffee during pregnancy: A reproductive hazard? Am J Obstet Gynecol 1991;164:1109-1114.
8. Barr HM, Streissguth AP: Caffeine use during pregnancy and Child outcome: A 7-year prospective study. Neurotoxicol Teratol 1991;13:441-448.
9. Nehlig A, Debry G: Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: A review on human and animal data. Neurotoxicol Teratol 1994;16:531-543.
10. Hughes HE, Goldstein DA: Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. J Med Genet 1988;25:396-399.
11. Friedman JM, Polifka JE: Teratogenic Effects of Drugs. A Resource for Clinicians (TERIS). Baltimore, Johns Hopkins University Press, 1994.
12. Bove FJ: The Story of Ergot. New York, Karger, 1970.
13. Rail TW: Oxytocin, prostaglandins, ergot alkaloids, and other drugs: Tocolytic agents, in Gilman AG, Rall TW, Nies AS, Taylor P (eds): The Pharmacologic Basis of Therapeutics. New York, Pergamon, 1990, pp 933-953.
14. Grauwiler J, Schön H: Teratological experiments with ergotamine in mice, rats, and rabbits. Teratology 1973;7:227-236.
15. Schön H, Leist KH, Grauwiler J: Single day treatment of pregnant rats with ergotamine, abstract. Teratology 1975;11:32A.
16. Spranger JW, Schinzel T, Myers T, et al: Cerebroarthrodigital syndrome: A newly recognized formal genesis syndrome in three patients with apparent arthromyodysplasia and sacral agenesis, brain malformation, and digital hypoplasia. Am J Med Genet 1980;5:13-24.
17. Graham JM Jr, Marin-Padilla M, Hoefnagel D: Jejunal atresia associated with Cafergot ingestion during pregnancy. Clin Pediatr 1983;22:226-228.
18. Verloes A, Emonts P, Dubois M, et al: Paraplegia and arthrogryposis multiplex of the lower extremities after intrauterine exposure to ergotamine. J Med Genet 1990;27:213-214.
19. Ulmann A, Silvestre L: RU486: The French experience. Hum Reprod 1994;9(Suppl 1):126-130.
20. Hausknect RU: Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:537-540.
21. Coelho HLL, Misago C, Fonseca WVC, et al: Selling abortifacients over the counter in pharmacies in Fortaleza, Brazil, letter. Lancet 1991;338:247.
22. Gonzalez CH, Vargas FR, Perez AB, et al: Limb deficiency with or without Möbius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993;47:59-64.
23. Schuler L, Ashton PW, Sanseverino MT: Teratogenicity of misoprostol. Lancet 1992;337:762-763.
24. Padget DH: The development of the cranial arteries in the human embryo. Contributions to Embryology, No. 212 1948;32:205-261.
25. Shepard TH: Möbius syndrome after misoprostol: A possible teratogenic mechanism, letter. Lancet 1995;346:780.
26. Firth HV, Boyd PA, Chamberlaine P, et al: Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet 1991;337:762-763.
27. Reid C, Hall JG, Anderson C, et al: Association of amyoplasia, bowel atresia, and defects of the musculature of the trunk. Am J Med Genet 1986;24:701-710.
28. Wynne-Davies R, Littlejohn A, Gormley J: Aetiology and interrelationship of some common skeletal deformities. (Talipes equinovarus and calcaneovalgus, metatarsus varus, congenital dislocation of the hip, and infantile idiopathic scoliosis). J Med Genet 1982;19:321-328.
29. Alderman BW, Takahashi ER, LeMier MK: Risk indicators for talipes equinovarus in Washington state, 1987-1989. Epidemiology 1991;2:289-292.